Literature DB >> 26646600

CHST14/D4ST1 deficiency: New form of Ehlers-Danlos syndrome.

Tomoki Kosho1.   

Abstract

Carbohydrate sulfotransferase 14/dermatan 4-O-sulfotransferase-1 (CHST14/D4ST1) deficiency represents a specific form of Ehlers-Danlos syndrome (EDS) caused by recessive loss-of-function mutations in CHST14. The disorder has been independently termed "adducted thumb-clubfoot syndrome", "EDS, Kosho type", and "EDS, musculocontractural type". To date, 31 affected patients from 21 families have been described. Clinically, CHST14/D4ST1 deficiency is characterized by multiple congenital malformations (craniofacial features including large fontanelle, hypertelorism, short and downslanting palpebral fissures, blue sclerae, short nose with hypoplastic columella, low-set and rotated ears, high palate, long philtrum, thin upper lip vermilion, small mouth, and micro-retrognathia; multiple congenital contractures including adduction-flexion contractures and talipes equinovarus as well as other visceral or ophthalmological malformations) and progressive multisystem fragility-related complications (skin hyperextensibility, bruisability, and fragility with atrophic scars; recurrent dislocations; progressive talipes or spinal deformities; pneumothorax or pneumohemothorax; large subcutaneous hematomas; and diverticular perforation). Etiologically, multisystem fragility is presumably caused by impaired assembly of collagen fibrils resulting from loss of dermatan sulfate (DS) in the decorin glycosaminoglycan side chain that promotes electrostatic binding between collagen fibrils. This is the first reported human disorder that specifically affects biosynthesis of DS. Its clinical characteristics indicate that CHST14/D4ST1 and, more fundamentally, DS, play a critical role in fetal development and maintenance of connective tissues in multiple organs. Considering that patients with CHST14/D4ST1 deficiency develop progressive multisystem fragility-related manifestations, establishment of a comprehensive and detailed natural history and health-care guidelines as well as further elucidation of the pathophysiology in view of future etiology-based therapy are crucial.
© 2015 Japan Pediatric Society.

Entities:  

Keywords:  Ehlers-Danlos syndrome; carbohydrate sulfotransferase 14; dermatan 4-O-sulfotransferase-1; dermatan sulfate

Mesh:

Substances:

Year:  2016        PMID: 26646600     DOI: 10.1111/ped.12878

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  17 in total

1.  Steroid Hormones Are Key Modulators of Tissue Mechanical Function via Regulation of Collagen and Elastic Fibers.

Authors:  Shanmugasundaram Nallasamy; Kyoko Yoshida; Meredith Akins; Kristin Myers; Renato Iozzo; Mala Mahendroo
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

2.  Vascular abnormalities in the placenta of Chst14-/- fetuses: implications in the pathophysiology of perinatal lethality of the murine model and vascular lesions in human CHST14/D4ST1 deficiency.

Authors:  Takahiro Yoshizawa; Shuji Mizumoto; Yuki Takahashi; Shin Shimada; Kazuyuki Sugahara; Jun Nakayama; Shin'ichi Takeda; Yoshihiro Nomura; Yuko Nitahara-Kasahara; Takashi Okada; Kiyoshi Matsumoto; Shuhei Yamada; Tomoki Kosho
Journal:  Glycobiology       Date:  2018-02-01       Impact factor: 4.313

Review 3.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

4.  Dermatan sulfate epimerase 1 and dermatan 4-O-sulfotransferase 1 form complexes that generate long epimerized 4-O-sulfated blocks.

Authors:  Emil Tykesson; Antti Hassinen; Katarzyna Zielinska; Martin A Thelin; Giacomo Frati; Ulf Ellervik; Gunilla Westergren-Thorsson; Anders Malmström; Sakari Kellokumpu; Marco Maccarana
Journal:  J Biol Chem       Date:  2018-07-05       Impact factor: 5.157

5.  Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.

Authors:  Lucia Micale; Carmela Fusco; Marco Castori
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Musculocontractural Ehlers-Danlos syndrome and neurocristopathies: dermatan sulfate is required for Xenopus neural crest cells to migrate and adhere to fibronectin.

Authors:  Nadège Gouignard; Marco Maccarana; Ina Strate; Kristoffer von Stedingk; Anders Malmström; Edgar M Pera
Journal:  Dis Model Mech       Date:  2016-04-21       Impact factor: 5.758

Review 7.  Pathophysiological Significance of Dermatan Sulfate Proteoglycans Revealed by Human Genetic Disorders.

Authors:  Shuji Mizumoto; Tomoki Kosho; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Pharmaceuticals (Basel)       Date:  2017-03-27

8.  The genetics of isolated and syndromic clubfoot.

Authors:  B Sadler; C A Gurnett; M B Dobbs
Journal:  J Child Orthop       Date:  2019-06-01       Impact factor: 1.548

9.  Gene expression of the two developmentally regulated dermatan sulfate epimerases in the Xenopus embryo.

Authors:  Nadège Gouignard; Tanja Schön; Christian Holmgren; Ina Strate; Emirhan Taşöz; Franziska Wetzel; Marco Maccarana; Edgar M Pera
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

10.  Craniofacial abnormality with skeletal dysplasia in mice lacking chondroitin sulfate N-acetylgalactosaminyltransferase-1.

Authors:  Hiroko Ida-Yonemochi; Wataru Morita; Nobuo Sugiura; Ryosuke Kawakami; Yuki Morioka; Yuka Takeuchi; Toshiya Sato; Shunichi Shibata; Hideto Watanabe; Takeshi Imamura; Michihiro Igarashi; Hayato Ohshima; Kosei Takeuchi
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.